Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Metadata
Title
Frequency and Significance of Anti-gliadin and Anti-endomysial Antibodies in Autoimmune Hepatitis
Authors
U. Volta
L. De Franceschi
N. Molinaro
F. Cassani
L. Muratori
M. Lenzi
F. B. Bianchi
A. J. Czaja
Publication date
01-10-1998
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 10/1998
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1023/A:1026650118759

Other articles of this Issue 10/1998

Digestive Diseases and Sciences 10/1998 Go to the issue

OriginalPaper

Expression of Fibroblast Growth Factor-1 and Fibroblast Growth Factor-2 in Normal Liver and Hepatocellular Carcinoma

OriginalPaper

Microflora of Gastric Biopsies from Patients with Duodenal Ulcer and Gastric Cancer (A Comparative Study of Patients from Korea, Colombia, and the United States)

OriginalPaper

Interleukin-8 Enhances Tetragastrin-Stimulated Acid Secretion In Vivo

Abstract List

Abstract of 3rd International Symposium on Experimental & New Therapeutic Approaches to Ulcer Disease

OriginalPaper

Indomethacin and Pancreatic Enzymes Synergistically Damage Intestine of Rats

OriginalPaper

Is Obesity a Significant Prognostic Factor in Acute Pancreatitis?
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits